Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
2016 Standout
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
2003
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Optimising antiemetic therapy: what are the problems and how can they be overcome?
2005
Risk?benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting
2004
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
New antiemetic drugs
2006
Does nicotinic acid (niacin) lower blood pressure?
2008
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration
1999
Cannabinoids and cancer: causation, remediation, and palliation
2005
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
2002 Standout
Aprepitant
2004
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Randomized, placebo‐controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting
2008
Nicotinic acid: an old drug with a promising future
2007
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
2012
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Incentive‐sensitization and addiction
2001 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine
1999
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Update on strategies to increase HDL quantity and function
2009
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
2010 Standout
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting
2003
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
Structures of membrane proteins
2010 StandoutNobel
Potential therapeutic targets for neurokinin-1 receptor antagonists
2004
5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods
2002 Standout
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
LTP and LTD
2004 Standout
The optimum zinc content in set calcium phosphate cement for promoting bone formation in vivo
2008
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
2007 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: A model of chemotherapy-related malaise?
2006 StandoutNobel
A Triple-Drug Combination to Prevent Nausea and Vomiting Following BEAM Chemotherapy Before Autologous Hematopoietic Stem Cell Transplantation
2011
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant
2004
Long-Term Antagonism of κ Opioid Receptors Prevents Escalation of and Increased Motivation for Heroin Intake
2013
Drug addiction as dopamine-dependent associative learning disorder
1999
Antileukotrienes in asthma: present situation
2001
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies
2000
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Fluorine in medicinal chemistry
2007 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Potential therapeutic targets for neurokinin-1 receptor antagonists
2004
Synthesis and characterization of mesoporous CaO–MO–SiO2–P2O5 (M = Mg, Zn, Cu) bioactive glasses/composites
2008
Chronic Morphine Treatment Modulates the Extracellular Levels of Endogenous Enkephalins in Rat Brain Structures Involved in Opiate Dependence: A Microdialysis Study
2002
Perspectives on low-density lipoprotein cholesterol goal achievement
2008
Substituted hydroxyapatites for bone regeneration: A review of current trends
2016
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
2008
Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
2007
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Bone Grafts and Substitutes in Dentistry: A Review of Current Trends and Developments
2021 Standout
Leukotriene Modifiers in Pediatric Asthma Management
2001
Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting
2004
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
1999
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE
2011
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
5‐Substituted 1H‐Tetrazoles as Carboxylic Acid Isosteres: Medicinal Chemistry and Synthetic Methods
2003 Standout
Calcium phosphates in biomedical applications: materials for the future?
2015 Standout
Works of N. Michiels being referenced
Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration
1996
Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1
2007
Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects
2003
Zinc supplementation increases bone alkaline phosphatase in healthy men
2001
Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers
2006
Montelukast Dose Selection in 6‐ to 14‐Year‐Olds: Comparison of Single‐Dose Pharmacokinetics in Children and Adults
1999
Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869
2002